Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grosset

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Revue Francaise Des Maladies Respiratoires|January 1, 1982
[Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections (author's transl)]J Grosset, R Bismuth, J Nguyen
Lancet (London, England)|September 5, 1992
Impact of BCG on tuberculous meningitis in France in 1990V Schwoebel, B Hubert, J Grosset
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1995
Surveillance of drug resistance for tuberculosis control: why and how?P Chaulet, F Boulahbal, J Grosset
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1994
Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccinationV Schwoebel, B Hubert, J Grosset
Pathologie-Biologie|May 1, 1983
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams]V Jarlier, R Bismuth, J Grosset
Tubercle|March 1, 1982
The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosisJ Grosset, C Truffot, C Boval
Revue Des Maladies Respiratoires|January 1, 1987
[BCG vaccination in France]J Grosset, V Jarlier, H Lecoeur
Bulletin of the International Union Against Tuberculosis|December 1, 1978
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]S Pretet, J Grosset, S Perdrizet
Revue De Tuberculose Et De Pneumologie|June 1, 1971
[Tuberculosis due to Mycobacterium africanum in African negroes in the Paris area]J Grosset, G Decroix, C Sors
La Nouvelle Presse Medicale|March 6, 1982
[Duration of the treatment of tuberculosis in 1981]C Sors, B Dautzenberg, J Grosset
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Revue Francaise Des Maladies Respiratoires|January 1, 1982
[Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections (author's transl)]J Grosset, R Bismuth, J Nguyen
Lancet (London, England)|September 5, 1992
Impact of BCG on tuberculous meningitis in France in 1990V Schwoebel, B Hubert, J Grosset
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1995
Surveillance of drug resistance for tuberculosis control: why and how?P Chaulet, F Boulahbal, J Grosset
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1994
Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccinationV Schwoebel, B Hubert, J Grosset
Pathologie-Biologie|May 1, 1983
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams]V Jarlier, R Bismuth, J Grosset
Tubercle|March 1, 1982
The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosisJ Grosset, C Truffot, C Boval
Revue Des Maladies Respiratoires|January 1, 1987
[BCG vaccination in France]J Grosset, V Jarlier, H Lecoeur
Bulletin of the International Union Against Tuberculosis|December 1, 1978
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]S Pretet, J Grosset, S Perdrizet
Revue De Tuberculose Et De Pneumologie|June 1, 1971
[Tuberculosis due to Mycobacterium africanum in African negroes in the Paris area]J Grosset, G Decroix, C Sors
La Nouvelle Presse Medicale|March 6, 1982
[Duration of the treatment of tuberculosis in 1981]C Sors, B Dautzenberg, J Grosset
Pageof 18